Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-27 @ 10:43 PM
Study NCT ID:
NCT04423861
Status:
UNKNOWN
Last Update Posted:
2022-10-31
First Post:
2020-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
Sponsor:
Azidus Brasil
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-08
First Submit QC Date:
None
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-27
Last Update Post Date:
2022-10-31
Last Update Post Date Type:
ACTUAL